Clinical Research on the Leading Causes of Severe Sight Impairment in the UK General and Working Populations

References

• Blindness and vision loss. National Health Serivce (NHS); 2021. Available from: https://www.nhs.uk/conditions/vision-loss/. Accessed October 8, 2022.
   Google Scholar
• The criteria for certification. The Royal National Institute of Blind People (RNIB); 2022. Available from: https://www.rnib.org.uk/your-eyes/navigating-sight-loss/registering-as-sight-impaired/the-criteria-for-certification/. Accessed December 20, 2022.
   Google Scholar
• Dementia and Disabilities Unit, Social Care, Ageing and Disability Directorate. Certificate of Vision Impairment: Explanatory Notes for Consultant Ophthalmologists and Hospital Eye Clinic Staff in England [Guidance]. Department of Health; 2017.
   Google Scholar
• Dewing JM, Lotery AJ, Ratnayaka JA. The disparity between funding for eye research vs. the high cost of sight-loss in the UK. Eye. 2023;37(4):584–586. doi:10.1038/s41433-022-02228-7
   PubMed Web of Science ®Google Scholar
• Burton M, Ramke J, Marques AP, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health. 2021;9(4):e489–e551. doi:10.1016/S2214-109X(20)30488-5
   PubMed Web of Science ®Google Scholar
• Fight for Sight. Time to Focus. Fight for Sight; 2020.
   Google Scholar
• Quartilho A, Simkiss P, Zekite A, Xing W, Wormald R, Bunce C. Leading causes of certifiable visual loss in England and Wales during the year ending 2013. Eye. 2016;30(4):602–607. doi:10.1038/eye.2015.288
   PubMed Web of Science ®Google Scholar
• Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open. 2014;4(2):e004015. doi:10.1136/bmjopen-2013-004015
   PubMed Web of Science ®Google Scholar
• Best Research for Best Health: the Next Chapter. National Institute for Health and Care Research (NIHR); 2021. Available from: https://www.nihr.ac.uk/documents/best-research-for-best-health-The-next-chapter/27778. Accessed December 20, 2022.
   Google Scholar
• The Sight Loss and Vision Priority Setting Partnership (SLV-PSP). Setting Priorities for Eye Research. James Lind Alliance; 2013. Available from: https://www.jla.nihr.ac.uk/priority-setting-partnerships/sight-loss-and-vision/downloads/SLV-PSP_Final_Report_v111.pdf. Accessed December 22, 2022.
   Google Scholar
• ICD-10 Version:2019. World Health Organization (WHO); 2019. Available from: https://icd.who.int/browse10/2019/en. Accessed October 8, 2022.
   Google Scholar
• Yonekawa Y, Miller JW, Kim IK. Age-related macular degeneration: advances in management and diagnosis. J Clin Med. 2015;4(2):343–359. doi:10.3390/jcm4020343
   PubMed Web of Science ®Google Scholar
• Slade J, Edwards E, White A. Royal National Institute of Blind People (RNIB). Employment status and sight loss. RNIB. 2017:57.
   Google Scholar
• Marques A, Ramke J, Cairns J, et al. Global economic productivity losses from vision impairment and blindness. EClinicalMedicine. 2021;35:100852. doi:10.1016/j.eclinm.2021.100852
   PubMedGoogle Scholar
• Tanna P, Strauss RW, Fujinami K, Michaelides M. Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol. 2017;101(1):25–30. doi:10.1136/bjophthalmol-2016-308823
   PubMed Web of Science ®Google Scholar
• Thompson D, Iannaccone A, Ali R, et al.; Monaciano Consortium. Advancing clinical trials for inherited retinal diseases: recommendations from the Second Monaciano Symposium. Transl Vis Sci Technol. 2020;9(7):2. doi:10.1167/tvst.9.7.2
   PubMed Web of Science ®Google Scholar
• Georgiou M, Fujinami K, Michaelides M. Inherited retinal diseases: therapeutics, clinical trials and end points-A review. Clin Exp Ophthalmol. 2021;49(3):270–288. doi:10.1111/ceo.13917
   PubMed Web of Science ®Google Scholar
• MacLaren RE. Electronic retinal implant surgery. Eye. 2017;31(2):191–195. doi:10.1038/eye.2016.280
   PubMed Web of Science ®Google Scholar
• Schwartz S, Regillo CD, Lam BL, et al. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label Phase 1/2 studies. Lancet. 2015;385(9967):509–516. doi:10.1016/S0140-6736(14)61376-3
   PubMed Web of Science ®Google Scholar
• Sahel J, Boulanger-Scemama E, Pagot C, et al. Partial recovery of visual function in a blind patient after optogenetic therapy. Nat Med. 2021;27(7):1223–1229. doi:10.1038/s41591-021-01351-4
   PubMed Web of Science ®Google Scholar
• Subbiah V. The next generation of evidence-based medicine. Nat Med. 2023;29(1):49–58. doi:10.1038/s41591-022-02160-z
   PubMed Web of Science ®Google Scholar
• Sahel J, Bennett J, Roska B. Depicting brighter possibilities for treating blindness. Sci Transl Med. 2019;11(494):eaax2324. doi:10.1126/scitranslmed.aax2324
   PubMed Web of Science ®Google Scholar
• Fortuny C, Flannery J. Mutation-independent gene therapies for rod-cone dystrophies. Adv Exp Med Biol. 2018;1074:75–81. doi:10.1007/978-3-319-75402-4_10
   PubMed Web of Science ®Google Scholar
• Ittoop S, Seibold L, Kahook M. Current opinion in ophthalmology: novel glaucoma devices in the pipeline. Curr Opin Ophthalmol. 2019;30(2):117–124. doi:10.1097/ICU.0000000000000555
   PubMed Web of Science ®Google Scholar
• Samuelson T, Chang DF, Marquis R, et al.; HORIZON Investigators. A Schlemm Canal Microstent for Intraocular Pressure Reduction in Primary Open-Angle Glaucoma and Cataract: the HORIZON Study. Ophthalmology. 2019;126(1):29–37. doi:10.1016/j.ophtha.2018.05.012
   PubMed Web of Science ®Google Scholar
• Jonas J, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. The Lancet. 2017;390(10108):2183–2193. doi:10.1016/S0140-6736(17)31469-1
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen A, Zou M, et al. Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017. BMJ Open. 2022;12(1):e053805. doi:10.1136/bmjopen-2021-053805
   PubMed Web of Science ®Google Scholar
• Mitry D, Bunce C, Wormald R, et al. Causes of certifications for severe sight impairment (blind) and sight impairment (partial sight) in children in England and Wales. Br J Ophthalmol. 2013;97(11):1431–1436. doi:10.1136/bjophthalmol-2013-303578
   PubMed Web of Science ®Google Scholar
• Bunce C, Zekite A, Wormald R, Bowman R. Is there evidence that the yearly numbers of children newly certified with sight impairment in England and Wales has increased between 1999/2000 and 2014/2015? A cross-sectional study. BMJ Open. 2017;7(9):e016888. doi:10.1136/bmjopen-2017-016888
   PubMed Web of Science ®Google Scholar
• Rahi JS, Cable N; British Childhood Visual Impairment Study Group. Severe visual impairment and blindness in children in the UK. The Lancet. 2003;362(9393):1359–1365. doi:10.1016/S0140-6736(03)14631-4
   PubMed Web of Science ®Google Scholar
• Barry R, Murray PI. Unregistered visual impairment: is registration a failing system? Br J Ophthalmol. 2005;89(8):995–998. doi:10.1136/bjo.2004.059915
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). International Classification of Diseases. Ninth Revision. 1977:578.
   Google Scholar
• Ahmad S, Kanukollu V Optic Atrophy. StatPearls. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559130/. Accessed July 7, 2023.
   Google Scholar